CREBBP.md
... ...
@@ -2,6 +2,8 @@
2 2
bibliography: 'morinlab.bib'
3 3
csl: 'NLM.csl'
4 4
link-citations: true
5
+nocite: |
6
+ @parryWholeExomeSequencing2013, @dunsCharacterizationDLBCLPMBL2021, @pasqualucciInactivatingMutationsAcetyltransferase2011, @loveGeneticLandscapeMutations2012
5 7
---
6 8
7 9
[[_TOC_]]
... ...
@@ -19,13 +21,7 @@ Mutations in CREBBP and EP300 affect a common pathway and have been described as
19 21
20 22
## Relevance tier by entity
21 23
22
-|Entity|Tier|Description |
23
-|:------:|:----:|--------------------------------------|
24
-|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@parryWholeExomeSequencing2013] |
25
-|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@dunsCharacterizationDLBCLPMBL2021] |
26
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] |
27
-|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] |
28
-|![BL](images/icons/BL_tier2.png) |2 |association with BL is tenuous[@loveGeneticLandscapeMutations2012]|
24
+[[include:table1_CREBBP.md]]
29 25
30 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
31 27
table1_CCT6B.md
... ...
@@ -0,0 +1,3 @@
1
+|Entity|Tier|Description |
2
+|:----:|:----:|------------------------------|
3
+|[BL]((images/icons/BL_tier3.png)) | 3 | Mutations are unlikely to be relevant to XXX|